Pharma Journalist -

SAGA Diagnostics AB, a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues,…
Read More...

AptarGroup, Inc. announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of…
Read More...

BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, announced it has licensed a new set of bacterial targets from JSR Corporation, for the…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan…
Read More...

GT Apeiron Therapeutics, a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery…
Read More...

Following the success of their ongoing alliance, Boehringer Ingelheim and the University of Dundee extend their collaboration to develop new medicines that target and destroy key cancer…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy in…
Read More...

Genmab A/S announced that it has entered into an exclusive worldwide license and option agreement with Janssen Biotech, Inc. (Janssen) to develop and commercialize HexaBody-CD38, a…
Read More...

Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, and Zai Lab Ltd., a China and U.S.-based innovative…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan…
Read More...